Analogic (NASDAQ:ALOG) issued its earnings results on Wednesday. The medical research company reported $0.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.32, reports. The firm had revenue of $106.90 million during the quarter, compared to analyst estimates of $100.55 million. Analogic had a negative net margin of 15.27% and a positive return on equity of 4.27%. The business’s revenue was down 11.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.43 earnings per share. Analogic updated its FY18 guidance to $2.75-2.90 EPS.

Shares of Analogic (NASDAQ ALOG) traded down $0.55 on Wednesday, hitting $81.05. 47,300 shares of the stock were exchanged, compared to its average volume of 94,605. The stock has a market capitalization of $1,018.75, a price-to-earnings ratio of 48.57, a P/E/G ratio of 4.16 and a beta of 0.86. Analogic has a 1 year low of $66.00 and a 1 year high of $91.40.

ALOG has been the subject of a number of recent analyst reports. Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $93.00 target price for the company in a research note on Tuesday, October 10th. Jefferies Group initiated coverage on shares of Analogic in a research note on Wednesday, August 9th. They set a “hold” rating and a $75.00 target price for the company. Four research analysts have rated the stock with a hold rating, The stock currently has an average rating of “Hold” and an average target price of $85.25.

WARNING: “Analogic (ALOG) Posts Earnings Results, Beats Expectations By $0.32 EPS” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at

Analogic Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Earnings History for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with's FREE daily email newsletter.